EU Indication Restricted For Novartis's Newly Approved Piqray
Patients Previously Treated With CDK 4/6 Inhibitors Are Excluded
• By Maureen Kenny
There was disagreement among EU regulators over what indication should be allowed • Source: Shutterstock 
